SCHEMBL6803832

SCHEMBL6803832

O=[C]Cc1ccc(CCn2cnc3ccccc32)cc1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.70
TDP1 Q9NUW8 1/20 0.58
EGLN3 Q9H6Z9 1/20 0.51
LTA4H P09960 1/20 0.51
LMNA P02545 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
CYP11B1 P15538 4/20 0.49
CYP11B2 P19099 4/20 0.49
MAPK1 P28482 1/20 0.49
TNF P01375 1/20 0.49
PKM P14618 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TSHR P16473 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALOX15 P16050 1/20 0.46
KMT2A Q03164 1/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784573 0.83 HTT (1.00) HTTTDP1EGLN3LTA4HLMNA
SCHEMBL13186931 0.81 HTT (0.77) HTTTDP1EGLN3LTA4HLMNA
SCHEMBL11313566 0.81 HTT (0.77) HTTTDP1EGLN3LTA4HLMNA
SCHEMBL16147345 0.81 HTT (0.77) HTTTDP1EGLN3LTA4HLMNA
Hydrochloric Acid SCHEMBL30341872 0.79 HTT (0.74) HTTTDP1EGLN3LTA4HLMNA
Hydrochloric Acid SCHEMBL29006871 0.79 HTT (0.74) HTTTDP1EGLN3LTA4HLMNA
SCHEMBL30581441 0.78 HTT (0.67) HTTTDP1EGLN3LMNASMN1; SMN2
SCHEMBL7259109 0.78 HTT (0.77) HTTTDP1EGLN3LTA4HLMNA
SCHEMBL24041763 0.77 HTT (0.70) HTTTDP1LTA4HLMNASMN1; SMN2
SCHEMBL24041750 0.76 L3MBTL1 (0.74) HTTTDP1LTA4HLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770647-B2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-03 US disclosed